# ICB_Rittmeyer

- **Read Paper:** [PMID: 27979383](https://pubmed.ncbi.nlm.nih.gov/27979383/)
- **Trial ID:** POPLAR / [NCT02008227](https://clinicaltrials.gov/study/NCT02008227)
- **Objective:** The trial evaluates the efficacy of atezolizumab versus chemotherapy in advanced non-small cell lung cancer (NSCLC), utilizing pre-treatment tumor transcriptomes from large clinical trials.
- **Data Source:** [EGAC00001002120](https://ega-archive.org/dacs/EGAC00001002120)
- **Clinical Data:** [EGAD00001008549](https://ega-archive.org/dacs/EGAD00001008549):  (includes treatment arm, histology, overall survival, progression-free survival, TLS-LA calls, and best confirmed overall response)
- **Processed Data:**
  - [EGAD00001008391](https://ega-archive.org/dacs/EGAC00001008391): Log2(TPM + 1) for 699 tumor samples profiled by RNA-seq for the entire transcriptome from OAK (GO28915).
  - [EGAD00001008628](https://ega-archive.org/dacs/EGAD00001008628): Counts for 699 tumor samples profiled by RNA-seq for the entire transcriptome from OAK (GO28915).


